Global leader in rare disease detection becomes stakeholder in Midlands Cancer Alliances' Life Science Innovation & Partnership Hub
LONDON, UK – September 5, 2025 – AnnieGuard Ltd, the global leader in rare disease detection technology, today announced it has been designated as a stakeholder to the Midlands Cancer Life Science Innovation & Partnership Hub, representing both the East Midlands Cancer Alliance (EMCA) and West Midlands Cancer Alliance (WMCA).
The strategic engagement positions AnnieGuard and its industry-leading SarcRisk engine as key contributors to collaborative efforts aimed at improving early detection and outcomes for sarcoma, a rare form of cancer, across the Midlands region.
"This stakeholder designation represents a significant validation of AnnieGuard's mission to prevent families from experiencing loss due to delayed sarcoma diagnosis," said Tiara Jamison, Founder and CEO of AnnieGuard Ltd. "Our SarcRisk engine uses...
